PS Gabapentin Capsule 50 mg (Pregabalin)

Adult dose

Pregabalin should be taken orally, divided into two doses per day, regardless of food. 1. Neuropathic pain - Peripheral neuropathic pain: Starting dose of 150 mg per day, may be increased to 300 mg per day after 3 to 7 days, and if necessary, may increase to a maximum of 600 mg per day at 7-day intervals. - Central neuropathic pain: Starting dose of 150 mg per day, may be increased to 300 mg per day after one week, and further adjusted to the target daily dose of 600 mg after one more week.

Child dose

Administration is not recommended for children under 12 years of age and adolescents aged 12-17 due to insufficient safety and efficacy data.

This drug may increase the risk of suicidal thoughts or behaviors, so it is essential to closely monitor mental health conditions such as depression or mood changes while taking this medication. Patients who are allergic to any of the ingredients in this drug or have specific hereditary lactose intolerance should not take it. Diabetic patients should be cautious as they may need to adjust their blood sugar control medications due to weight gain after taking this drug. If serious allergic reactions like angioedema occur, patients should immediately stop taking the medication and consult their healthcare provider. Elderly patients may have an increased risk of falls due to dizziness or drowsiness, especially during the initial phase of treatment. Blurry vision or changes in vision may occur, and patients should consult their doctors if these symptoms arise. Stopping this medication abruptly may result in withdrawal symptoms such as insomnia, headache, and anxiety, so dosage should be gradually reduced following a doctor's instructions. Patients with a history of substance abuse should use this medication cautiously as the risk of abuse may be higher. Patients with impaired kidney function may need dosage adjustments, so consultation with their healthcare provider is recommended. Patients with severe heart disease need to be cautious when taking this drug. Taking this drug with other CNS depressants or opioids may increase the risk of respiratory depression and should be approached with caution. Early in pregnancy, there may be a risk of congenital disabilities for the fetus, so pregnant women should avoid taking this drug or consult with their doctor. Nursing women should consider discontinuing breastfeeding or the medication itself since this drug may be excreted in breast milk, and they should discuss this with their healthcare provider. Drivers and operators of hazardous machinery should refrain from doing so until dizziness and drowsiness resolve. In case of overdose, patients should seek medical attention immediately for appropriate treatment, and blood dialysis may be required if necessary. This drug should be stored out of reach of children, and it is safest not to transfer it to another container. If severe rashes, swelling, difficulty breathing, or other symptoms occur while taking this medication, patients should stop taking it immediately and consult their healthcare provider.

Serious side effects

• Hives
• severe swelling (edema)
• angioedema
• facial swelling
• Stevens-Johnson syndrome
• toxic epidermal necrolysis
• cold sweat
• chest tightness
• difficulty breathing
• respiratory distress

Mild side effects

• Dizziness
• drowsiness
• confusion
• loss of orientation
• irritability
• depression
• euphoric feelings
• decreased libido
• insomnia
• depersonalization

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is best kept at room temperature between 15 and 30 degrees Celsius. Avoid storing it in excessively hot or cold places to help maintain its effectiveness.

Appearance

A hard capsule with a dark blue upper part and a white lower part containing white powder.

Package unit

30 capsules per bottle